What Happened?
Pleasanton, CA-based ProSomnus Appointed Brian Dow as Chief Financial Officer
About the Company
ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus`s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus`s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
About the Person
Brian Dow is Chief Financial Officer at ProSomnus. Previously, Brian held various senior HR leadership roles in the industry.
Info Source
News
Short Profile